Cargando…
Lack of Induction of RBD-Specific Neutralizing Antibodies despite Repeated Heterologous SARS-CoV-2 Vaccination Leading to Seroconversion and Establishment of T Cell-Specific Memory in a Patient in Remission of Multiple Myeloma
Background: Prophylactic vaccination against infectious diseases may induce a state of long-term protection in the otherwise healthy host. However, the situation is less predictable in immunocompromised patients and may require adjustment of vaccination schedules and/or basic therapy. Methods: A pat...
Autores principales: | Kratzer, Bernhard, Trapin, Doris, Gattinger, Pia, Oberhofer, Teresa, Sehgal, Al Nasar Ahmed, Waidhofer-Söllner, Petra, Rottal, Arno, Körmöczi, Ulrike, Grabmeier-Pfistershammer, Katharina, Kopetzky, Gerhard H., Tischer, Franz, Valenta, Rudolf, Pickl, Winfried F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949333/ https://www.ncbi.nlm.nih.gov/pubmed/35335006 http://dx.doi.org/10.3390/vaccines10030374 |
Ejemplares similares
-
Combined assessment of S‐ and N‐specific IL‐2 and IL‐13 secretion and CD69 neo‐expression for discrimination of post–infection and post‐vaccination cellular SARS‐CoV‐2‐specific immune response
por: Kratzer, Bernhard, et al.
Publicado: (2022) -
Immunological imprint of COVID‐19 on human peripheral blood leukocyte populations
por: Kratzer, Bernhard, et al.
Publicado: (2020) -
Omicron: A SARS‐CoV‐2 variant of real concern
por: Gattinger, Pia, et al.
Publicado: (2022) -
FcγR requirements and costimulatory capacity of Urelumab, Utomilumab, and Varlilumab
por: Leitner, Judith, et al.
Publicado: (2023) -
BTLA inhibition has a dominant role in the cis-complex of BTLA and HVEM
por: Battin, Claire, et al.
Publicado: (2022)